MEDNAX (MD) Tops Q2 EPS by 9c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. TFII
9. LYB
10. RXRX

Go back to MEDNAX (MD) Tops Q2 EPS by 9c

Mednax Reports Second Quarter Results

August 6, 2021 6:00 AM EDT

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- Mednax, Inc. (NYSE: MD), the national medical group specializing in prenatal, neonatal, and pediatric services, today reported earnings from continuing operations of $0.36 per share for the three months ended June 30, 2021. On a non-GAAP basis, Mednax reported Adjusted EPS from continuing operations of $0.41.

For the 2021 second quarter, Mednax reported the following results from continuing operations:

Net revenue of $473 million; Income from continuing operations of $31 million; and Adjusted EBITDA of $66 million.

Strong patient volume trends across the spectrum of... More